Latest filing published 13 Feb 2026 for Prestige Consumer Healthcare Inc., €55k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jeffrey Zerillo, listed as senior executive, appears in our data through filings on Prestige Consumer Healthcare Inc. shares, published by SEC (Form 4). Between 3 May 2021 and 11 February 2026, the trades on record add up to 19 filings.
No open-market purchase appears, only 2 sales worth €93k. Outside the open market, there are 17 share grants. In 2026 alone, the filings show no purchases and 1 sale.
On 13 February 2026 came the latest disclosure, an open-market sale for €55k in Prestige Consumer Healthcare Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations